rs13407983

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020458.4(TTC7A):​c.1066-13G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 1,613,518 control chromosomes in the GnomAD database, including 15,110 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2728 hom., cov: 32)
Exomes 𝑓: 0.13 ( 12382 hom. )

Consequence

TTC7A
NM_020458.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.281

Publications

5 publications found
Variant links:
Genes affected
TTC7A (HGNC:19750): (tetratricopeptide repeat domain 7A) This gene encodes a protein containing tetratricopeptide repeats. Mutations in this gene disrupt intestinal development and can cause early onset inflammatory bowel disease and intestinal atresia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
TTC7A Gene-Disease associations (from GenCC):
  • gastrointestinal defects and immunodeficiency syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • multiple intestinal atresia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-47005909-G-A is Benign according to our data. Variant chr2-47005909-G-A is described in ClinVar as Benign. ClinVar VariationId is 403573.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC7ANM_020458.4 linkc.1066-13G>A intron_variant Intron 8 of 19 ENST00000319190.11 NP_065191.2 Q9ULT0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC7AENST00000319190.11 linkc.1066-13G>A intron_variant Intron 8 of 19 2 NM_020458.4 ENSP00000316699.5 Q9ULT0-1

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
25823
AN:
151974
Hom.:
2721
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.284
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.152
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0976
Gnomad FIN
AF:
0.129
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.130
Gnomad OTH
AF:
0.171
GnomAD2 exomes
AF:
0.130
AC:
32638
AN:
250978
AF XY:
0.128
show subpopulations
Gnomad AFR exome
AF:
0.287
Gnomad AMR exome
AF:
0.132
Gnomad ASJ exome
AF:
0.145
Gnomad EAS exome
AF:
0.000924
Gnomad FIN exome
AF:
0.131
Gnomad NFE exome
AF:
0.134
Gnomad OTH exome
AF:
0.136
GnomAD4 exome
AF:
0.125
AC:
183011
AN:
1461426
Hom.:
12382
Cov.:
32
AF XY:
0.125
AC XY:
90583
AN XY:
727004
show subpopulations
African (AFR)
AF:
0.299
AC:
10022
AN:
33466
American (AMR)
AF:
0.136
AC:
6082
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.145
AC:
3786
AN:
26132
East Asian (EAS)
AF:
0.000680
AC:
27
AN:
39700
South Asian (SAS)
AF:
0.101
AC:
8729
AN:
86250
European-Finnish (FIN)
AF:
0.131
AC:
6960
AN:
53238
Middle Eastern (MID)
AF:
0.166
AC:
959
AN:
5766
European-Non Finnish (NFE)
AF:
0.125
AC:
138461
AN:
1111764
Other (OTH)
AF:
0.132
AC:
7985
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
7633
15266
22899
30532
38165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4896
9792
14688
19584
24480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.170
AC:
25863
AN:
152092
Hom.:
2728
Cov.:
32
AF XY:
0.168
AC XY:
12482
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.285
AC:
11798
AN:
41464
American (AMR)
AF:
0.162
AC:
2478
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.152
AC:
525
AN:
3464
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5188
South Asian (SAS)
AF:
0.0975
AC:
469
AN:
4810
European-Finnish (FIN)
AF:
0.129
AC:
1366
AN:
10588
Middle Eastern (MID)
AF:
0.146
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
0.130
AC:
8809
AN:
67980
Other (OTH)
AF:
0.169
AC:
358
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1000
2001
3001
4002
5002
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.143
Hom.:
2431
Bravo
AF:
0.177
Asia WGS
AF:
0.0630
AC:
219
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied by a panel of primary immunodeficiencies. Number of patients: 26. Only high quality variants are reported. -

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Multiple gastrointestinal atresias Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
9.4
DANN
Benign
0.77
PhyloP100
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13407983; hg19: chr2-47233048; API